#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4150992	B	Inhibition of FAM-labeled ZBA248 binding to recombinant human BRD4 bromodomain 1 (44 to 168 residues) expressed in Rosetta2 Escherichia coli DE3 cells after 30 mins by fluorescence polarization assay	Homo sapiens	31	ALA4145654	cell-based format	Scientific Literature
2.	ALA4185403	F	Growth inhibition of human MOLM13 cells after 4 days by WST-8 assay	Homo sapiens	34	ALA4184143	cell-based format	Scientific Literature
3.	ALA4185404	F	Growth inhibition of human MV4-11 cells after 4 days by WST-8 assay	Homo sapiens	34	ALA4184143	cell-based format	Scientific Literature
4.	ALA4185405	B	Inhibition of FAM-labeled ZBA248 binding to recombinant human N-terminal His6-tagged BRD4 bromodomain 2 (333 to 460 residues) expressed in Rosetta2 DE3 cells after 30 mins by Flourescence polarization assay	Homo sapiens	37	ALA4184143	cell-based format	Scientific Literature
5.	ALA4185406	F	Cytotoxicity against human HCC1395 cells assessed as cell growth inhibition after 4 days by WST-8 assay	Homo sapiens	1	ALA4184143	cell-based format	Scientific Literature
6.	ALA4185407	F	Cytotoxicity against human SUM149PT cells assessed as cell growth inhibition after 4 days by WST-8 assay	Homo sapiens	1	ALA4184143	cell-based format	Scientific Literature
7.	ALA4185408	B	Inhibition of human PLK4 (M1 to S273 residues) expressed in mammalian expression system	Homo sapiens	1	ALA4184143	assay format	Scientific Literature
8.	ALA4185409	T	Toxicity in SCID mouse implanted with human MDA-MB-231 cells assessed as weight loss at 40 mg/kg, po qd measured 2 to 3 times weekly during treatment and weekly post dose	Mus musculus	1	ALA4184143	organism-based format	Scientific Literature
9.	ALA4185410	B	Inhibition of FAM-labeled ZBA248 binding to recombinant human N-terminal His6-tagged BRD4 bromodomain 1 (44 to 168 residues) expressed in Rosetta2 DE3 cells after 30 mins by Flourescence polarization assay	Homo sapiens	37	ALA4184143	cell-based format	Scientific Literature
10.	ALA4185412	A	Half life in Sprague-Dawley rat at 25 mg/kg, po by LC/MS method	Rattus norvegicus	2	ALA4184143	organism-based format	Scientific Literature
11.	ALA4185413	A	Cmax in Sprague-Dawley rat at 25 mg/kg, po by LC/MS method	Rattus norvegicus	2	ALA4184143	organism-based format	Scientific Literature
12.	ALA4185414	A	AUC (0 to t) in Sprague-Dawley rat at 25 mg/kg, po by LC/MS method	Rattus norvegicus	2	ALA4184143	organism-based format	Scientific Literature
13.	ALA4185415	A	Half life in Sprague-Dawley rat at 5 mg/kg, iv by LC/MS method	Rattus norvegicus	1	ALA4184143	organism-based format	Scientific Literature
14.	ALA4185416	A	Clearance in Sprague-Dawley rat at 25 mg/kg, po by LC/MS method	Rattus norvegicus	2	ALA4184143	organism-based format	Scientific Literature
15.	ALA4185417	A	Oral bioavailability in Sprague-Dawley rat at 25 mg/kg by LC/MS method	Rattus norvegicus	1	ALA4184143	organism-based format	Scientific Literature
16.	ALA4185418	A	AUC (0 to t) in Sprague-Dawley rat at 5 mg/kg, iv by LC/MS method	Rattus norvegicus	1	ALA4184143	organism-based format	Scientific Literature
17.	ALA4185419	A	Volume of distribution at steady state in Sprague-Dawley rat at 5 mg/kg, iv by LC/MS method	Rattus norvegicus	1	ALA4184143	organism-based format	Scientific Literature
18.	ALA4185420	A	Clearance in Sprague-Dawley rat at 5 mg/kg, iv by LC/MS method	Rattus norvegicus	1	ALA4184143	organism-based format	Scientific Literature
19.	ALA4185421	A	Half life in SCID mouse at 5 mg/kg, iv by LC/MS method	Mus musculus	1	ALA4184143	organism-based format	Scientific Literature
20.	ALA4185422	A	AUC (0 to t) in SCID mouse at 5 mg/kg, iv by LC/MS method	Mus musculus	1	ALA4184143	organism-based format	Scientific Literature